**5. Conclusions**

We report a potential increased risk of severity and mortality in COVID-19 patients with liver diseases and CKD. This study will facilitate better clinical managemen<sup>t</sup> and inform the process of implementing more stringent preventative measures for this group of patients.

**Author Contributions:** Conceptualization, T.O. and J.A.; methodology, T.O.; software, T.O.; validation, T.O., J.A., G.C.; formal analysis, T.O.; investigation, T.O.; resources, T.O.; data curation, T.O., G.C.; writing—original draft preparation, T.O.; writing—review and editing, T.O., J.A., G.C.; visualization, G.C.; supervision, T.O.; project administration, T.O. All authors have read and agreed to the published version of the manuscript.

**Funding:** This research received no external funding.

**Conflicts of Interest:** The authors declare no conflict of interest.
